Frequent Links
Geographic-information-system-high-impact-factor-journalsPolitical-economy-InnovationsOral HealthBiotechnologyCochlear Implant Journalsscholarly-open-access-climate-change-journalsDental TraumatologyEffluent treatment Scientific JournalsComputed Tomography Irrigation engineering-Articles-open-accessPhysical Medicine Journals listEnergy managementOpen access journals in toxicologyHypernatremiaOpen Access textileengineering Journals
(R)-3-Nitrobiphenyline
200px | |
Systematic (IUPAC) name | |
---|---|
(R)-2-[1-(3'-Nitrobiphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole | |
Clinical data | |
MedlinePlus | a682611 |
Identifiers | |
7px | |
PubChem | CID 16757089 |
ChemSpider | 23288036 7px |
ChEMBL | CHEMBL242693 7px |
Chemical data | |
Formula | C17H17N3O3 |
311.334 g/mol | |
| |
14px (what is this?) (verify) |
(R)-3-Nitrobiphenyline is a drug which acts as an α2-adrenergic agonist, selective for the α2C subtype, as well as being a weak antagonist at the α2A and α2B subtypes.[1]
References
- ^ Crassous PA, Cardinaletti C, Carrieri A, Bruni B, Di Vaira M, Gentili F, Ghelfi F, Giannella M, Paris H, Piergentili A, Quaglia W, Schaak S, Vesprini C, Pigini M (August 2007). "Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist". Journal of Medicinal Chemistry 50 (16): 3964–8. PMID 17630725. doi:10.1021/jm061487a.
Lua error in package.lua at line 80: module 'Module:Buffer' not found.